Donga Socio Holdings
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of S… Read more
Donga Socio Holdings - Asset Resilience Ratio
Donga Socio Holdings (000640) has an Asset Resilience Ratio of 1.85% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Donga Socio Holdings's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Donga Socio Holdings's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩37.95 Billion | 1.85% |
| Total Liquid Assets | ₩37.95 Billion | 1.85% |
Asset Resilience Insights
- Limited Liquidity: Donga Socio Holdings maintains only 1.85% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Donga Socio Holdings Industry Peers by Asset Resilience Ratio
Compare Donga Socio Holdings's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Donga Socio Holdings (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Donga Socio Holdings.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.49% | ₩9.95 Billion | ₩2.03 Trillion | -1.59pp |
| 2023-12-31 | 2.08% | ₩40.64 Billion | ₩1.96 Trillion | +1.46pp |
| 2022-12-31 | 0.61% | ₩10.63 Billion | ₩1.73 Trillion | -2.86pp |
| 2021-12-31 | 3.48% | ₩58.84 Billion | ₩1.69 Trillion | -0.21pp |
| 2020-12-31 | 3.68% | ₩55.67 Billion | ₩1.51 Trillion | -0.35pp |
| 2019-12-31 | 4.03% | ₩54.81 Billion | ₩1.36 Trillion | +3.56pp |
| 2018-12-31 | 0.48% | ₩5.93 Billion | ₩1.24 Trillion | +0.40pp |
| 2017-12-31 | 0.08% | ₩1.11 Billion | ₩1.46 Trillion | -0.10pp |
| 2016-12-31 | 0.17% | ₩2.43 Billion | ₩1.40 Trillion | -0.13pp |
| 2015-12-31 | 0.30% | ₩3.70 Billion | ₩1.22 Trillion | +0.09pp |
| 2014-12-31 | 0.21% | ₩2.25 Billion | ₩1.08 Trillion | -0.52pp |
| 2013-12-31 | 0.73% | ₩7.20 Billion | ₩988.28 Billion | +0.52pp |
| 2012-12-31 | 0.21% | ₩3.59 Billion | ₩1.72 Trillion | -2.77pp |
| 2011-12-31 | 2.98% | ₩44.45 Billion | ₩1.49 Trillion | +2.16pp |
| 2010-12-31 | 0.82% | ₩10.09 Billion | ₩1.23 Trillion | +0.66pp |
| 2009-12-31 | 0.16% | ₩1.69 Billion | ₩1.06 Trillion | -0.43pp |
| 2008-12-31 | 0.59% | ₩4.52 Billion | ₩769.94 Billion | -0.37pp |
| 2007-12-31 | 0.96% | ₩6.83 Billion | ₩713.72 Billion | +0.05pp |
| 2006-12-31 | 0.91% | ₩6.62 Billion | ₩731.74 Billion | -0.35pp |
| 2005-12-31 | 1.25% | ₩9.08 Billion | ₩724.29 Billion | +0.04pp |
| 2004-12-31 | 1.21% | ₩8.56 Billion | ₩706.01 Billion | -1.10pp |
| 2003-12-31 | 2.31% | ₩15.98 Billion | ₩691.41 Billion | +0.08pp |
| 2002-12-31 | 2.23% | ₩13.18 Billion | ₩590.72 Billion | -2.21pp |
| 2001-12-31 | 4.44% | ₩26.35 Billion | ₩593.63 Billion | +0.49pp |
| 2000-12-31 | 3.95% | ₩21.63 Billion | ₩547.36 Billion | -- |